You just read:

Pivotal Phase 2/3 Trial of Olipudase Alfa for Adult Patients With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease Type B) to Begin in the UK

News provided by

Sanofi Genzyme

03 Nov, 2016, 08:20 ET